Amedeo Smart

Free Medical Literature Service

 

Amedeo

Liver Diseases
  Free Subscription

Articles published in
Semin Liver Dis
    April 2024
  1. SAVIANO A, Roehlen N, Baumert TF
    Tight Junction Proteins as Therapeutic Targets to Treat Liver Fibrosis and Hepatocellular Carcinoma.
    Semin Liver Dis. 2024 Apr 22. doi: 10.1055/s-0044-1785646.
    >> Share

    March 2024
  2. KODAMA T, Takehara T
    Molecular genealogy of metabolic-associated hepatocellular carcinoma.
    Semin Liver Dis. 2024 Mar 18. doi: 10.1055/a-2289-2298.
    >> Share

    February 2024
  3. ROMERO-GOMEZ M, Arab JP, Oliveira CP, Hernandez M, et al
    Is There a Safe Alcohol Consumption Limit for the General Population and in Patients with Liver Disease?
    Semin Liver Dis. 2024;44:69-78.
    >> Share

  4. CANIVET CM, Boursier J, Loomba R
    New Nomenclature for Nonalcoholic Fatty Liver Disease: Understanding Metabolic Dysfunction-Associated Steatotic Liver Disease, Metabolic Dysfunction- and Alcohol-Associated Liver Disease, and Their Implications in Clinical Practice.
    Semin Liver Dis. 2024;44:35-42.
    >> Share

  5. MOUZAKI M, Woo JG, Divanovic S
    Gestational and Developmental Contributors of Pediatric MASLD.
    Semin Liver Dis. 2024;44:43-53.
    >> Share

  6. TUTUSAUS A, Morales A, Garcia de Frutos P, Mari M, et al
    GAS6/TAM Axis as Therapeutic Target in Liver Diseases.
    Semin Liver Dis. 2024;44:99-114.
    >> Share

  7. BESSONE F, Hillotte GL, Ahumada N, Jaureguizahar F, et al
    UDCA for Drug-Induced Liver Disease: Clinical and Pathophysiological Basis.
    Semin Liver Dis. 2024;44:1-22.
    >> Share

  8. EL-KASSAS M, Awad A, Elbadry M, Arab JP, et al
    Tailored Model of Care for Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease.
    Semin Liver Dis. 2024;44:54-68.
    >> Share

  9. BECH KT, Lindvig KP, Thiele M, Castera L, et al
    Algorithms for Early Detection of Silent Liver Fibrosis in the Primary Care Setting.
    Semin Liver Dis. 2024;44:23-34.
    >> Share

    January 2024
  10. LIU H, Sethi V, Li X, Xiao Y, et al
    Liver Transplantation for Hepatocellular Carcinoma: A Narrative Review and A Glimpse into The Future.
    Semin Liver Dis. 2024 Jan 11. doi: 10.1055/a-2242-7543.
    >> Share

    November 2023
  11. BALOGUN O, Nejak-Bowen K
    The Hepatic Porphyrias: Revealing the Complexities of a Rare Disease.
    Semin Liver Dis. 2023 Nov 16. doi: 10.1055/s-0043-1776760.
    >> Share

  12. WILSON SR, Duncan AW
    The Ploidy State as a Determinant of Hepatocyte Proliferation.
    Semin Liver Dis. 2023 Nov 15. doi: 10.1055/a-2211-2144.
    >> Share

  13. HAN X, Sun Q, Xu M, Zhu G, et al
    Unraveling the Complexities of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma.
    Semin Liver Dis. 2023 Nov 6. doi: 10.1055/s-0043-1776127.
    >> Share

  14. SAEIDINEJAD M, Elshabrawi A, Sriphoosanaphan S, Andreola F, et al
    Novel Therapeutic Approaches in Treatment of Acute-on-Chronic Liver Failure.
    Semin Liver Dis. 2023;43:429-445.
    >> Share

  15. DUTTA RK, Jun J, Du K, Diehl AM, et al
    Hedgehog Signaling: Implications in Liver Pathophysiology.
    Semin Liver Dis. 2023;43:418-428.
    >> Share

    August 2023
  16. PEKARSKA K, Parker R
    Alcohol-Related Liver Disease: Is There a Safe Alcohol Consumption Limit for Liver Disease?
    Semin Liver Dis. 2023;43:305-310.
    >> Share

  17. RANJBARIAN T, Schnabl B
    Gut Microbiome-Centered Therapies for Alcohol-Associated Liver Disease.
    Semin Liver Dis. 2023;43:311-322.
    >> Share

  18. DESHMUKH K, Apte U
    The Role of Endoplasmic Reticulum Stress Response in Liver Regeneration.
    Semin Liver Dis. 2023;43:279-292.
    >> Share

  19. MEADOWS V, Yang Z, Basaly V, Guo GL, et al
    FXR Friend-ChIPs in the Enterohepatic System.
    Semin Liver Dis. 2023;43:267-278.
    >> Share

  20. COOPER SA, Kostallari E, Shah VH
    Angiocrine Signaling in Sinusoidal Health and Disease.
    Semin Liver Dis. 2023;43:245-257.
    >> Share

  21. RUIZ M, Lacaille F, Schrader C, Pons M, et al
    Pediatric and Adult Liver Disease in Alpha-1 Antitrypsin Deficiency.
    Semin Liver Dis. 2023;43:258-266.
    >> Share

    May 2023
  22. KOTULKAR M, Robarts D, Apte U
    HNF4-alpha in hepatocyte health and disease.
    Semin Liver Dis. 2023 May 22. doi: 10.1055/a-2097-0660.
    >> Share

  23. VANDERSCHUEREN E, Trebicka J, Laleman W
    Endoscopic Advances in Hepatology.
    Semin Liver Dis. 2023 May 16. doi: 10.1055/s-0043-1769009.
    >> Share

  24. ADORI M, Bhat S, Gramignoli R, Valladolid-Acebes I, et al
    Hepatic Innervations and Nonalcoholic Fatty Liver Disease.
    Semin Liver Dis. 2023 May 8. doi: 10.1055/s-0043-57237.
    >> Share

  25. GOLABI P, Shah D, Younossi ZM
    How to Identify Advanced Nonalcoholic Fatty Liver Disease in the Primary Care Setting.
    Semin Liver Dis. 2023;43:142-148.
    >> Share

  26. REVERTER E, Toapanta D, Bassegoda O, Zapatero J, et al
    Critical Care Management of Acute-on-Chronic Liver Failure: Certainties and Unknowns.
    Semin Liver Dis. 2023;43:206-217.
    >> Share

  27. GU W, Kimmann M, Laleman W, Praktiknjo M, et al
    To TIPS or Not to TIPS in High Risk of Variceal Rebleeding and Acute-on-Chronic Liver Failure.
    Semin Liver Dis. 2023;43:189-205.
    >> Share

  28. BERNARD JK, Marakovits C, Smith LG, Francis H, et al
    Mast Cell and Innate Immune Cell Communication in Cholestatic Liver Disease.
    Semin Liver Dis. 2023;43:226-233.
    >> Share

  29. SINGH S, Kumar PVSNK, Kumar JP, Tomo S, et al
    Genetic and Epigenetic Basis of Drug-Induced Liver Injury.
    Semin Liver Dis. 2023;43:163-175.
    >> Share

  30. URIAS E, Chen VL
    Screening for At-Risk Nonalcoholic Fatty Liver Disease in the Primary Care Setting.
    Semin Liver Dis. 2023;43:133-141.
    >> Share

    February 2023
  31. KIM M, Rizvi F, Shin D, Gouon-Evans V, et al
    Update on Hepatobiliary Plasticity.
    Semin Liver Dis. 2023 Feb 10. doi: 10.1055/s-0042-1760306.
    >> Share

  32. KELTY TJ, Dashek RJ, Arnold WD, Rector RS, et al
    Emerging Links between Nonalcoholic Fatty Liver Disease and Neurodegeneration.
    Semin Liver Dis. 2023;43:77-88.
    >> Share

  33. OXLEY M, Francis H, Sato K
    Growth Hormone Signaling in Liver Diseases: Therapeutic Potentials and Controversies.
    Semin Liver Dis. 2023;43:24-30.
    >> Share

  34. CHOLANKERIL G, El-Serag HB
    Current Challenges and Future Direction in Surveillance for Hepatocellular Carcinoma in Patients with Nonalcoholic Fatty Liver Disease.
    Semin Liver Dis. 2023;43:89-99.
    >> Share

    January 2023
  35. SMITH TN, Gallo De Moraes A, Simonetto DA
    Cirrhosis management in the Intensive Care Unit.
    Semin Liver Dis. 2023 Jan 18. doi: 10.1055/a-2015-1290.
    >> Share

    December 2022
  36. BANC-HUSU AM, Shiau H, Dike P, Shneider BL, et al
    Beyond Varices: Complications of Cirrhotic Portal Hypertension in Pediatrics.
    Semin Liver Dis. 2022 Dec 26. doi: 10.1055/s-0042-1759613.
    >> Share

  37. LITTLE A, Medford A, O'Brien A, Childs J, et al
    Recent Advances in Intrahepatic Biliary Epithelial Heterogeneity.
    Semin Liver Dis. 2022 Dec 15. doi: 10.1055/s-0042-1758833.
    >> Share

    November 2022
  38. ROMERO-GOMEZ M, Aller R, Martin-Bermudo F
    Dietary Recommendations for the Management of Non-alcoholic Fatty Liver Disease (NAFLD): A Nutritional Geometry Perspective.
    Semin Liver Dis. 2022;42:434-445.
    >> Share

  39. CHEN B, Tang WHW, Rodriguez M, Corey KE, et al
    NAFLD in Cardiovascular Diseases: A Contributor or Comorbidity?
    Semin Liver Dis. 2022;42:465-474.
    >> Share

  40. PARK Y, Thadasina D, Bolujo I, Isidan A, et al
    Three-Dimensional Organoids as a Model to Study Nonalcoholic Fatty Liver Disease.
    Semin Liver Dis. 2022;42:423-433.
    >> Share

  41. MOTOMURA T, Faccioli LAP, Diaz-Aragon R, Kocas-Kilicarslan ZN, et al
    From a Single Cell to a Whole Human Liver: Disease Modeling and Transplantation.
    Semin Liver Dis. 2022;42:413-422.
    >> Share

  42. HUANG DQ, Downes M, Evans RM, Witztum JL, et al
    Shared Mechanisms between Cardiovascular Disease and NAFLD.
    Semin Liver Dis. 2022;42:455-464.
    >> Share

    October 2022
  43. JUANOLA A, Ma AT, Pose E, Gines P, et al
    Novel biomarkers of AKI in cirrhosis.
    Semin Liver Dis. 2022 Oct 3. doi: 10.1055/a-1954-4136.
    >> Share

    September 2022
  44. GALA K, Abdul Razzak F, Rapaka B, Dayyeh Bk A, et al
    Novel Endoscopic Bariatric Therapies for the Management of Non-Alcoholic Steatohepatitis.
    Semin Liver Dis. 2022 Sep 18. doi: 10.1055/a-1946-6285.
    >> Share

  45. GOFTON C, Agar M, George J
    Early Implementation of Palliative and Supportive Care in Hepatocellular Carcinoma.
    Semin Liver Dis. 2022 Sep 17. doi: 10.1055/a-1946-5592.
    >> Share

  46. RASHA F, Paul S, Simon TG, Hoshida Y, et al
    Hepatocellular carcinoma chemoprevention with generic agents.
    Semin Liver Dis. 2022 Sep 14. doi: 10.1055/a-1942-6693.
    >> Share

    August 2022
  47. TUJIOS S, Stravitz RT, Lee WM
    Management of Acute Liver Failure: Update 2022.
    Semin Liver Dis. 2022;42:362-378.
    >> Share

  48. CARVALHO-GONTIJO R, Han C, Zhang L, Zhang V, et al
    Metabolic Injury of Hepatocytes Promotes Progression of NAFLD and AALD.
    Semin Liver Dis. 2022;42:233-249.
    >> Share

  49. CASTERA L, Boursier J
    Noninvasive Algorithms for the Case Finding of "At-Risk" Patients with NAFLD.
    Semin Liver Dis. 2022;42:313-326.
    >> Share

  50. EL-KASSAS M, Cabezas J, Coz PI, Zheng MH, et al
    Nonalcoholic Fatty Liver Disease: Current Global Burden.
    Semin Liver Dis. 2022;42:401-412.
    >> Share

  51. ATIF J, Thoeni C, Bader GD, McGilvray ID, et al
    Unraveling the Complexity of Liver Disease One Cell at a Time.
    Semin Liver Dis. 2022;42:250-270.
    >> Share

  52. NEVENS F, van der Merwe S
    Mesenchymal Stem Cell Transplantation in Liver Diseases.
    Semin Liver Dis. 2022;42:283-292.
    >> Share

    June 2022
  53. GARCIA-SAENZ-DE-SICILIA M, Al-Obaid L, Hughes DL, Duarte-Rojo A, et al
    Mastering core recommendations during HEPAtology ROUNDS in advanced chronic liver disease.
    Semin Liver Dis. 2022 Jun 28. doi: 10.1055/a-1886-5909.
    >> Share

  54. CHEW N, Ng CH, Truong E, Noureddin M, et al
    Non-Alcoholic Steatohepatitis Drug Development Pipeline: An Update.
    Semin Liver Dis. 2022 Jun 16. doi: 10.1055/a-1877-9656.
    >> Share

  55. KULKARNI AV, Premkumar M, Arab JP, Kumar K, et al
    EARLY DIAGNOSIS AND PREVENTION OF INFECTIONS IN CIRRHOSIS.
    Semin Liver Dis. 2022 Jun 7. doi: 10.1055/a-1869-7607.
    >> Share

    May 2022
  56. GRINSPAN LT, Villanueva A
    Biomarker Development Using Liquid Biopsy in Hepatocellular Carcinoma.
    Semin Liver Dis. 2022;42:188-201.
    >> Share

  57. YUAN WZ, Fu T
    Liver Dysfunction in COVID-19: From Onset to Recovery.
    Semin Liver Dis. 2022;42:151-158.
    >> Share

  58. GUPTA B, Rai R, Oertel M, Raeman R, et al
    Intestinal Barrier Dysfunction in Fatty Liver Disease: Roles of Microbiota, Mucosal Immune System, and Bile Acids.
    Semin Liver Dis. 2022;42:122-137.
    >> Share

  59. TARLI C, Mirijello A, Addolorato G
    Treating Alcohol Use Disorder in Patients with Alcohol-Associated Liver Disease: Controversies in Pharmacological Therapy.
    Semin Liver Dis. 2022;42:138-150.
    >> Share

  60. FASULLO M, Shah T, Zhou H, Siddiqui MS, et al
    Post-Transplant Biliary Strictures: An Updated Review.
    Semin Liver Dis. 2022;42:225-232.
    >> Share

  61. CARROLL HK, Duffy AG, O'Farrelly C
    Liver Immunology, Immunotherapy, and Liver Cancers: Time for a Rethink?
    Semin Liver Dis. 2022;42:212-224.
    >> Share

    February 2022
  62. GALLAHER CE, Shawcross DL
    Management of multidrug-resistant infections in cirrhosis.
    Semin Liver Dis. 2022 Feb 7. doi: 10.1055/a-1765-0056.
    >> Share

  63. PANDAY R, Monckton CP, Khetani SR
    The Role of Liver Zonation in Physiology, Regeneration, and Disease.
    Semin Liver Dis. 2022;42:1-16.
    >> Share

  64. CADAMURO M, Lasagni A, Sarcognato S, Guido M, et al
    The Neglected Role of Bile Duct Epithelial Cells in NASH.
    Semin Liver Dis. 2022;42:34-47.
    >> Share

  65. TERZI E, Ayuso C, Piscaglia F, Bruix J, et al
    Liver Imaging Reporting and Data System: Review of Pros and Cons.
    Semin Liver Dis. 2022;42:104-111.
    >> Share

    November 2021
  66. TELLEZ L, Rodriguez de Santiago E, Albillos A
    Fontan-Associated Liver Disease: Pathophysiology, Staging, and Management.
    Semin Liver Dis. 2021;41:538-550.
    >> Share

  67. RADUN R, Trauner M
    Role of FXR in Bile Acid and Metabolic Homeostasis in NASH: Pathogenetic Concepts and Therapeutic Opportunities.
    Semin Liver Dis. 2021;41:461-475.
    >> Share

  68. MAIWALL R, Sarin SK
    Plasma Exchange in Acute and Acute on Chronic Liver Failure.
    Semin Liver Dis. 2021;41:476-494.
    >> Share

  69. GU X, Lu Q, Zhang C, Tang Z, et al
    Clinical Application and Progress of Fecal Microbiota Transplantation in Liver Diseases: A Review.
    Semin Liver Dis. 2021;41:495-506.
    >> Share

  70. MENDOZA YP, Becchetti C, Watt KD, Berzigotti A, et al
    Risks and Rewards of Bariatric Surgery in Advanced Chronic Liver Diseases.
    Semin Liver Dis. 2021;41:448-460.
    >> Share

  71. HASHEM A, Khalouf A, Acosta A
    Management of Obesity and Nonalcoholic Fatty Liver Disease: A Literature Review.
    Semin Liver Dis. 2021;41:435-447.
    >> Share

  72. ARRESE M, Arab JP, Barrera F, Kaufmann B, et al
    Insights into Nonalcoholic Fatty-Liver Disease Heterogeneity.
    Semin Liver Dis. 2021;41:421-434.
    >> Share

  73. KOHUT TJ, Gilbert MA, Loomes KM
    Alagille Syndrome: A Focused Review on Clinical Features, Genetics, and Treatment.
    Semin Liver Dis. 2021;41:525-537.
    >> Share

  74. LI N, Yamamoto G, Fuji H, Kisseleva T, et al
    Interleukin-17 in Liver Disease Pathogenesis.
    Semin Liver Dis. 2021;41:507-515.
    >> Share

    October 2021
  75. JENG WJ, Liaw YF
    Erratum to: Finite Antiviral Therapy in Chronic Hepatitis B Patients with Cirrhosis.
    Semin Liver Dis. 2021 Oct 1. doi: 10.1055/s-0041-1737024.
    >> Share

    September 2021
  76. MARIN JJG, Romero MR, Herraez E, Asensio M, et al
    Mechanisms of Pharmacoresistance in Hepatocellular Carcinoma: New Drugs but Old Problems.
    Semin Liver Dis. 2021 Sep 20. doi: 10.1055/s-0041-1735631.
    >> Share

    August 2021
  77. SHERMAN M
    Assessing Toxicity in Drug Trials in Liver Disease.
    Semin Liver Dis. 2021;41:277-284.
    >> Share

  78. KAWAGUCHI T, Charlton M, Kawaguchi A, Yamamura S, et al
    Effects of Mediterranean Diet in Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review, Meta-Analysis, and Meta-Regression Analysis of Randomized Controlled Trials.
    Semin Liver Dis. 2021;41:225-234.
    >> Share

  79. ZELBER-SAGI S
    Dietary Treatment for NAFLD: New Clinical and Epidemiological Evidence and Updated Recommendations.
    Semin Liver Dis. 2021;41:248-262.
    >> Share

  80. NILLES KM, Levitsky J
    Current and Evolving Indications for Simultaneous Liver Kidney Transplantation.
    Semin Liver Dis. 2021;41:308-320.
    >> Share

  81. MA L, Khatib S, Craig AJ, Wang XW, et al
    Toward a Liver Cell Atlas: Understanding Liver Biology in Health and Disease at Single-Cell Resolution.
    Semin Liver Dis. 2021;41:321-330.
    >> Share

  82. MOLLER S, Kimer N, Kronborg T, Grandt J, et al
    Nonalcoholic Fatty Liver Disease and Cardiovascular Disease: Overlapping Mechanisms.
    Semin Liver Dis. 2021;41:235-247.
    >> Share

  83. ENGELMANN C, Martino VD, Kerbert AJC, Weil-Verhoeven D, et al
    The Current Status of Granulocyte-Colony Stimulating Factor to Treat Acute-on-Chronic Liver Failure.
    Semin Liver Dis. 2021;41:298-307.
    >> Share

    July 2021
  84. VAZ K, Goodwin T, Kemp W, Roberts S, et al
    Artificial Intelligence in Hepatology: A Narrative Review.
    Semin Liver Dis. 2021 Jul 29. doi: 10.1055/s-0041-1731706.
    >> Share

  85. ZHOU Y, Tao J, Calvisi DF, Chen X, et al
    Role of Lipogenesis Rewiring in Hepatocellular Carcinoma.
    Semin Liver Dis. 2021 Jul 26. doi: 10.1055/s-0041-1731709.
    >> Share

  86. KAHL S, Putzer J, Roden M
    Novel Antidiabetic Strategies and Diabetologists' Views in Nonalcoholic Steatohepatitis.
    Semin Liver Dis. 2021 Jul 21. doi: 10.1055/s-0041-1732354.
    >> Share

    June 2021
  87. JENG WJ, Liaw YF
    Finite Antiviral Therapy in Chronic Hepatitis B Patients with Cirrhosis.
    Semin Liver Dis. 2021 Jun 28. doi: 10.1055/s-0041-1729973.
    >> Share

  88. HSU YC, Tseng CH, Huang YT, Yang HI, et al
    Application of Risk Scores for Hepatocellular Carcinoma in Patients with Chronic Hepatitis B: Current Status and Future Perspective.
    Semin Liver Dis. 2021 Jun 23. doi: 10.1055/s-0041-1730924.
    >> Share

  89. BRESSON-HADNI S, Spahr L, Chappuis F
    Hepatic Alveolar Echinococcosis.
    Semin Liver Dis. 2021 Jun 23. doi: 10.1055/s-0041-1730925.
    >> Share

  90. SU YY, Li CC, Lin YJ, Hsu C, et al
    Adjuvant versus Neoadjuvant Immunotherapy for Hepatocellular Carcinoma: Clinical and Immunologic Perspectives.
    Semin Liver Dis. 2021 Jun 15. doi: 10.1055/s-0041-1730949.
    >> Share

    May 2021
  91. HAEP N, Florentino RM, Squires JE, Bell A, et al
    The Inside-Out of End-Stage Liver Disease: Hepatocytes are the Keystone.
    Semin Liver Dis. 2021 May 15. doi: 10.1055/s-0041-1725023.
    >> Share

  92. USON JUNIOR PLS, Nagalo BM, Ahn DH, Bekaii-Saab T, et al
    Combination Immunotherapy for Hepatocellular Carcinoma: Where Are We Currently?
    Semin Liver Dis. 2021 May 6. doi: 10.1055/s-0040-1722646.
    >> Share

  93. MOECKLI B, Majno P, Orci LA, Peloso A, et al
    Liver Transplantation Selection and Allocation Criteria for Hepatocellular Carcinoma: A European Perspective.
    Semin Liver Dis. 2021 May 6. doi: 10.1055/s-0041-1723032.
    >> Share

  94. SEKIBA K, Otsuka M, Koike K
    Potential of HBx Gene for Hepatocarcinogenesis in Noncirrhotic Liver.
    Semin Liver Dis. 2021 May 6. doi: 10.1055/s-0041-1723033.
    >> Share

  95. GIL-GOMEZ A, Brescia P, Rescigno M, Romero-Gomez M, et al
    Gut-Liver Axis in Nonalcoholic Fatty Liver Disease: the Impact of the Metagenome, End Products, and the Epithelial and Vascular Barriers.
    Semin Liver Dis. 2021;41:191-205.
    >> Share

  96. ORTIZ V, Ellenberg SS, Weinberg EM
    Blinding in Clinical Trials for Chronic Liver Diseases.
    Semin Liver Dis. 2021;41:163-171.
    >> Share

  97. DUNN MA, Kappus MR, Bloomer PM, Duarte-Rojo A, et al
    Wearables, Physical Activity, and Exercise Testing in Liver Disease.
    Semin Liver Dis. 2021;41:128-135.
    >> Share

    January 2021
  98. HARTMANN P, Schnabl B
    New Developments in Microbiome in Alcohol-Associated and Nonalcoholic Fatty Liver Disease.
    Semin Liver Dis. 2021;41:87-102.
    >> Share

  99. FERREIRA-GONZALEZ S, Rodrigo-Torres D, Gadd VL, Forbes SJ, et al
    Cellular Senescence in Liver Disease and Regeneration.
    Semin Liver Dis. 2021;41:50-66.
    >> Share

  100. WANG H, Calvisi DF, Chen X
    Organoids for the Study of Liver Cancer.
    Semin Liver Dis. 2021;41:19-27.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016